Healthcare provider profile · identity verified

Andrea B Mccarty, DO

Family Practice · WICHITA, KS · NPI 1063470938

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	667	156
Levothyroxine Sodium	Levothyroxine Sodium	568	119
Omeprazole	Omeprazole	483	108
Lisinopril	Lisinopril	390	96
Amlodipine Besylate	Amlodipine Besylate	300	77
Simvastatin	Simvastatin	292	66
Metformin Hcl	Metformin Hcl	256	63
Gabapentin	Gabapentin	254	49
Pantoprazole Sodium	Pantoprazole Sodium	244	66
Trazodone Hcl	Trazodone Hcl	229	46
Metoprolol Tartrate	Metoprolol Tartrate	217	58
Losartan Potassium	Losartan Potassium	215	54
Sertraline Hcl	Sertraline Hcl	204	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	202	37
Tramadol Hcl	Tramadol Hcl	198	37
Hydrochlorothiazide	Hydrochlorothiazide	196	44
Furosemide	Furosemide	189	49
Fluticasone Propionate	Fluticasone Propionate	185	40
Potassium Chloride	Potassium Chloride	179	45
Zolpidem Tartrate	Zolpidem Tartrate	167	23
Ozempic	Semaglutide	138	24
Escitalopram Oxalate	Escitalopram Oxalate	135	23
Meloxicam	Meloxicam	135	33
Jardiance	Empagliflozin	132	25
Rosuvastatin Calcium	Rosuvastatin Calcium	121	35
Bupropion Xl	Bupropion Hcl	119	22
Duloxetine Hcl	Duloxetine Hcl	109	20
Citalopram Hbr	Citalopram Hydrobromide	103	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	99	15
Allopurinol	Allopurinol	98	20
Metformin Hcl Er	Metformin Hcl	91	20
Montelukast Sodium	Montelukast Sodium	85	18
Oxybutynin Chloride Er	Oxybutynin Chloride	84	18
Metoprolol Succinate	Metoprolol Succinate	81	19
Eliquis	Apixaban	80	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	18
Synthroid	Levothyroxine Sodium	80	15
Fluoxetine Hcl	Fluoxetine Hcl	78	16
Famotidine	Famotidine	76	21
Lorazepam	Lorazepam	76	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	72	20
Baclofen	Baclofen	70	13
Venlafaxine Hcl Er	Venlafaxine Hcl	64	12
Alprazolam	Alprazolam	63	16
Clopidogrel	Clopidogrel Bisulfate	63	14
Fenofibrate	Fenofibrate	62	suppressed
Pregabalin	Pregabalin	62	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	59	21
Pravastatin Sodium	Pravastatin Sodium	55	11
Tizanidine Hcl	Tizanidine Hcl	55	20
Ropinirole Hcl	Ropinirole Hcl	54	13
Myrbetriq	Mirabegron	53	suppressed
Prednisone	Prednisone	53	48
Hydroxyzine Hcl	Hydroxyzine Hcl	49	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	11
Tresiba Flextouch U-100	Insulin Degludec	46	11
Tresiba Flextouch U-200	Insulin Degludec	46	suppressed
Alendronate Sodium	Alendronate Sodium	45	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	16
Diclofenac Sodium	Diclofenac Sodium	45	suppressed
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	44	16
Warfarin Sodium	Warfarin Sodium	43	suppressed
Fluconazole	Fluconazole	40	17
Cephalexin	Cephalexin	38	28
Buspirone Hcl	Buspirone Hcl	36	11
Albuterol Sulfate	Albuterol Sulfate	35	suppressed
Lovastatin	Lovastatin	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Carvedilol	Carvedilol	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Celecoxib	Celecoxib	31	suppressed
Bumetanide	Bumetanide	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	16
Mirtazapine	Mirtazapine	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	25
Atenolol	Atenolol	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Ondansetron Odt	Ondansetron	26	13
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Azithromycin	Azithromycin	24	23
Clonidine Hcl	Clonidine Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Nystatin	Nystatin	22	suppressed
Cefdinir	Cefdinir	21	21
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Finasteride	Finasteride	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Ketoconazole	Ketoconazole	17	14
Methocarbamol	Methocarbamol	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Primidone	Primidone	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Glimepiride	Glimepiride	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Metolazone	Metolazone	13	suppressed
Risperidone	Risperidone	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Vienva	Levonorgestrel/Ethin.Estradiol	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Digoxin	Digoxin	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Estradiol	Estradiol	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Trospium Chloride Er	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error